Outcomes of 44 Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion 17p

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2018.07.292
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Bortezomib and Dexamethasone Consolidation Following Risk-Adapted Melphalan and Stem Cell Transplantation for Patients With Newly Diagnosed Light-Chain Amyloidosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

EGCG Inhibits Fibrillation of Light Chain 6aJL2-R24g, Associated With Light Chain Amyloidosis

Biophysical Journal
Biophysics
2018English

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation

JAMA network open
Medicine
2020English

A Case of Systemic Amyloidosis Associated With Multiple Myeloma Diagnosed With Skin Findings

Turkiye Klinikleri Dermatoloji
Dermatology
2020English

Systemic Light Chain Amyloidosis Mimicking Rheumatic Disorders

Case Reports in Medicine
Medicine
2016English

CVID Associated With Systemic Amyloidosis

Case Reports in Immunology
AllergyImmunology
2015English

Treatment Patterns and Clinical Outcomes in High-Risk Newly Diagnosed Multiple Myeloma Patients Carrying the 17p Deletion: An Observational Multi-Center Retrospective Study

American Journal of Hematology
Hematology
2018English

Systemic Light Chain Amyloidosis With Cardiac and Renal Involvements in a Patient With Heart Failure

Cardiology and Cardiovascular Medicine
2017English

Treatment Patterns and Outcome Following Initial Relapse or Refractory Disease in Patients With Systemic Light Chain Amyloidosis

American Journal of Hematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy